Literature DB >> 25613392

Unplanned resection of a soft tissue sarcoma: clinical characteristics and impact on oncological and functional outcomes.

Takeshi Morii1, Takayuki Aoyagi, Takashi Tajima, Akira Yoshiyama, Shouichi Ichimura, Kazuo Mochizuki.   

Abstract

BACKGROUND: Over the past three decades, several studies have reported worse outcomes with unplanned resection for malignant soft tissue tumors. However, the impact of these studies on preventing unnecessary unplanned resection remains unknown.
METHODS: In a retrospective survey on the treatment of soft tissue sarcomas, we compared cases of unplanned resection with cases of planned resection in terms of the properties of unplanned resection and the oncological and functional outcomes. For the unplanned resection cases, an additional wide resection was performed.
RESULTS: Of 92 cases, unplanned resection was performed in 24 (26 %). Small or subcutaneous tumors were significantly more frequently subjected to unplanned resection. In 17 of 24 unplanned resection cases, residual tumors (70.8 %) were noted. Plastic surgery was more frequently needed for unplanned resection cases. There was no significant difference between the unplanned resection and control cases with regard to oncological outcome. However, as to local recurrence and overall survival, the events occurred only in the cases with residual tumors in the additional wide resection specimen in the unplanned resection group. There was no significant difference in functional evaluation, except for emotional acceptance, which had a better score in the unplanned resection group.
CONCLUSIONS: Despite repeated cautions regarding unplanned resection in terms of its inadequate procedure which contradicts the principles of soft tissue sarcoma treatment, unplanned resections are still frequently performed. Perhaps the small size and subcutaneous location of the sarcomas in the unplanned resection group did not evoke the probability of malignancy for the surgeons who initially managed them. Even though an additional wide resection was performed, a residual tumor would lead to a worse outcome. An effective awareness program to avoid unnecessary unplanned resections for soft tissue sarcoma should be considered.

Entities:  

Mesh:

Year:  2015        PMID: 25613392     DOI: 10.1007/s00776-014-0689-x

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  12 in total

1.  Differential diagnosis between benign and malignant soft tissue tumors utilizing ultrasound parameters.

Authors:  Takeshi Morii; Tomonori Kishino; Naoko Shimamori; Mitsue Motohashi; Hiroaki Ohnishi; Keita Honya; Takayuki Aoyagi; Takashi Tajima; Shoichi Ichimura
Journal:  J Med Ultrason (2001)       Date:  2017-06-20       Impact factor: 1.314

2.  Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).

Authors:  Javier Martin-Broto; Nadia Hindi; Josefina Cruz; Javier Martinez-Trufero; Claudia Valverde; Luis M De Sande; Angeles Sala; Lorena Bellido; Ana De Juan; Jordi Rubió-Casadevall; Roberto Diaz-Beveridge; Ricardo Cubedo; Oscar Tendero; Diego Salinas; Isidro Gracia; Rafael Ramos; Silvia Baguè; Antonio Gutierrez; José Duran-Moreno; Antonio Lopez-Pousa
Journal:  Oncologist       Date:  2018-11-08

3.  Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis.

Authors:  Akshay Tiwari; Swati Shah; Ashwani Kumar Sharma; Sandeep Mehta; Ullas Batra; S K Sharma; A K Dewan
Journal:  Indian J Surg Oncol       Date:  2016-11-02

4.  Outcomes of unplanned sarcoma excision: impact of residual disease.

Authors:  Chris Charoenlap; Jungo Imanishi; Takaaki Tanaka; John Slavin; Samuel Y Ngan; Sarat Chander; Michelle Maree Dowsey; Chatar Goyal; Peter F M Choong
Journal:  Cancer Med       Date:  2016-03-01       Impact factor: 4.452

5.  Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall.

Authors:  Hina Saeed; David M King; Candice A Johnstone; John A Charlson; Donald A Hackbarth; John C Neilson; Manpreet Bedi
Journal:  Int J Surg Oncol       Date:  2016-10-10

6.  Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.

Authors:  Maria Anna Smolle; Dimosthenis Andreou; Per-Ulf Tunn; Joanna Szkandera; Bernadette Liegl-Atzwanger; Andreas Leithner
Journal:  EFORT Open Rev       Date:  2017-10-17

7.  The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre Study.

Authors:  Maria Anna Smolle; Per-Ulf Tunn; Elisabeth Goldenitsch; Florian Posch; Joanna Szkandera; Marko Bergovec; Bernadette Liegl-Atzwanger; Andreas Leithner
Journal:  Ann Surg Oncol       Date:  2017-01-20       Impact factor: 5.344

8.  Evaluation of Planned versus Unplanned Soft-Tissue Sarcoma Resection Using PROMIS Measures.

Authors:  Benjamin K Wilke; Anna R Cooper; Ashley K Aratani; Mark T Scarborough; C Parker Gibbs; Andre Spiguel
Journal:  Sarcoma       Date:  2019-03-05

9.  Surgery in reference centers improves survival of sarcoma patients: a nationwide study.

Authors:  J-Y Blay; C Honoré; E Stoeckle; P Meeus; M Jafari; F Gouin; P Anract; G Ferron; A Rochwerger; M Ropars; S Carrere; F Marchal; F Sirveaux; A Di Marco; L R Le Nail; J Guiramand; G Vaz; J-C Machiavello; O Marco; S Causeret; P Gimbergues; F Fiorenza; L Chaigneau; F Guillemin; J-M Guilloit; F Dujardin; J-P Spano; J-C Ruzic; A Michot; P Soibinet; E Bompas; C Chevreau; F Duffaud; M Rios; C Perrin; N Firmin; F Bertucci; C Le Pechoux; F Le Loarer; O Collard; M Karanian-Philippe; M Brahmi; A Dufresne; A Dupré; F Ducimetière; A Giraud; D Pérol; M Toulmonde; I Ray-Coquard; A Italiano; A Le Cesne; N Penel; S Bonvalot
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

10.  Improved survival using specialized multidisciplinary board in sarcoma patients.

Authors:  J-Y Blay; P Soibinet; N Penel; E Bompas; F Duffaud; E Stoeckle; O Mir; J Adam; C Chevreau; S Bonvalot; M Rios; P Kerbrat; D Cupissol; P Anract; F Gouin; J-E Kurtz; C Lebbe; N Isambert; F Bertucci; M Toumonde; A Thyss; S Piperno-Neumann; P Dubray-Longeras; P Meeus; F Ducimetière; A Giraud; J-M Coindre; I Ray-Coquard; A Italiano; A Le Cesne
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.